Nature's Sunshine Products Inc (NATR) FinancialsNATRNature's Sunshine Products Inc

Nature's Sunshine Products Inc (NATR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is General health, accounting for 39.9% of total sales, equivalent to $49.07M. Other significant revenue streams include Digestive and Cardiovascular. Understanding this composition is critical for investors evaluating how NATR navigates market cycles within the Food Processing industry.

Evaluating the bottom line, Nature's Sunshine Products Inc maintains a gross margin of 72.86%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.53%, while the net margin is 1.62%. These profitability ratios, combined with a Return on Equity (ROE) of 8.66%, provide a clear picture of how effectively NATR converts its operational activities into shareholder value.

In the context of the broader market, NATR competes directly with industry leaders such as ARTV and NAGE. With a market capitalization of $225.98M, it holds a leading position in the sector. When comparing efficiency, NATR's gross margin of 72.86% stands against ARTV's N/A and NAGE's N/A. Such benchmarking helps identify whether Nature's Sunshine Products Inc is trading at a premium or discount relative to its financial performance.

Nature's Sunshine has shown fluctuating revenue, with Q2 2026 revenue at $117 million, a 1.9% increase year-over-year but below expectations. Gross margins are strong at 73.66%, and the forward P/E ratio is 8.87, indicating potential value. However, net income has been inconsistent, with a recent decline to $3.54 million in Q2 2026.